世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

遺伝子組換えヒト骨形成タンパク質9試薬の世界市場インサイト、2031年までの予測

遺伝子組換えヒト骨形成タンパク質9試薬の世界市場インサイト、2031年までの予測


Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Market Insights, Forecast to 2031

世界の遺伝子組換えヒト骨形成タンパク質9試薬市場は、2025年の1億700万米ドルから2031年には1億6500万米ドルに成長し、予測期間中の年間平均成長率（CAGR）は7.5％になると予測されている。 骨形成タンパク質（... もっと見る

　

　

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ 		2025年4月11日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

世界の遺伝子組換えヒト骨形成タンパク質9試薬市場は、2025年の1億700万米ドルから2031年には1億6500万米ドルに成長し、予測期間中の年間平均成長率（CAGR）は7.5％になると予測されている。
骨形成タンパク質（BMP）は、ヒト卵巣卵胞のさまざまな細胞タイプで発現し、卵巣機能の調節に重要な役割を果たしている。BMP-9は成長分化因子-2（GDF-2）としても知られ、トランスフォーミング成長因子-β（TGF-β）スーパーファミリーに属する。BMP-9は主に肝臓で合成され、血液中に分泌されることにより、様々な生理的および病理学的機能を調節している。

遺伝子組換えヒト骨形成タンパク質9試薬の米国・カナダ市場は、2025年の100万ドルから2031年には100万ドルに達すると推定され、2025年から2031年までの予測期間中に年平均成長率（CAGR）％で増加する。
遺伝子組換えヒト骨形成タンパク質9試薬の中国市場は、2025年の100万ドルから2031年には100万ドルに達すると推定され、2025年から2031年の予測期間中のCAGRは%である。
遺伝子組換えヒト骨形成タンパク質9試薬のヨーロッパ市場は、2025年の100万ドルから2031年には100万ドルに達すると推定され、2025年から2031年の予測期間中のCAGRは%です。

組換えヒト骨形成タンパク質9試薬の世界の主要メーカーには、Thermo Fisher Scientific Inc.、Bio-Techne、Scientists Helping Scientists、Abcam Limited、FUJIFILM Irvine Scientific、BD Biosciences、Bio-Rad Laboratories, Inc.、BPS Bioscience, Inc.、Elabscience、Yisheng Biotechnology (Shanghai) Co., Ltd.などがある。2024年、世界の上位5社の売上高シェアは約 %であった。
消費面では、組み換えヒト骨形成タンパク質9試薬の地域別（地域レベル、国レベル）、企業別、タイプ別、用途別の売上高に焦点を当てています。

本レポートは、遺伝子組換えヒト骨形成タンパク質9試薬の世界市場の概要、生産能力、生産高、収益、価格を紹介しています。2020年～2025年の過去の市場収益/販売データ、2025年の推定値、2031年までのCAGR予測による世界市場動向の分析。
本レポートでは、遺伝子組換えヒト骨形成タンパク質9試薬の主要生産者を調査し、主要地域と国の消費量も提供しています。組換え型ヒト骨形成促進タンパク質9試薬の今後の市場可能性のハイライトと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国の注目点。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。

本レポートでは、2020年から2025年までの組換えヒト骨形成タンパク質9試薬の売上高、収益、市場シェア、主要メーカーの業界ランキングに焦点を当てます。世界の遺伝子組換えヒト骨形成タンパク質9試薬市場における主要な利害関係者を特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。
本レポートでは、2020年から2031年までのタイプ別、用途別のセグメントデータ、売上高、収益、価格を分析しています。遺伝子組換えヒト骨形成タンパク質9試薬の売上高、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。
Thermo Fisher Scientific Inc.、Bio-Techne、Scientists Helping Scientists、Abcam Limited、FUJIFILM Irvine Scientific、BD Biosciences、Bio-Rad Laboratories, Inc.、BPS Bioscience, Inc.、Elabscience、Yisheng Biotechnology (Shanghai) Co., Ltd.など、世界の主要企業の詳細な企業プロフィール。

市場セグメンテーション
企業別
サーモフィッシャーサイエンティフィック
バイオテクネ
科学者を助ける科学者
アブカム社
富士フイルムアーバインサイエンティフィック
BDバイオサイエンス
バイオ・ラッド・ラボラトリーズ
BPSバイオサイエンス社
エラブサイエンス
益盛生物技術（上海）有限公司
アブカイン
北京生物創意科技有限公司
上海亜滋生物技術有限公司
セルバース
大連美潤生物技術有限公司
シノバイオロジカル
プロスペック・タニー・テクノジーン社
ENZO
タイプ別セグメント
純度＜95
純度95％以上
用途別セグメント
大学
研究センター
地域別生産量
北米
欧州
中国
日本
地域別売上高
米国およびカナダ
米国
カナダ
中国
アジア（中国を除く）
日本
韓国
中国 台湾
東南アジア
欧州
ドイツ
フランス
英国
イタリア
ロシア
中東、アフリカ、中南米
ブラジル
メキシコ
トルコ
イスラエル

各章の概要
第1章：報告書のスコープ、市場セグメント（タイプ別、用途別など）の概要、各市場セグメントの市場規模、今後の発展可能性などを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。
第2章 組換え型ヒト骨形成タンパク質9試薬の世界、地域レベル、国レベルでの販売（消費）、収益各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場空間、生産能力などを紹介しています。
第3章：遺伝子組換えヒト骨形成タンパク質9試薬メーカーの競争環境、価格、売上高、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。
第4章：タイプ別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。
第5章：読者が異なる下流市場のブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの売上高、収益、平均価格、発展可能性をカバーする、アプリケーション別の様々な市場セグメントの分析を提供します。
第6章 北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。
第7章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高、収益。
第8章：中国：タイプ別、用途別、セグメント別の売上高と収益。
第9章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。
第10章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。
第11章：主要メーカーのプロフィールを提供し、製品の説明や仕様、組み換えヒト骨形成タンパク質9試薬の売上高、収益、価格、粗利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。
第12章：産業チェーン、販売チャネル、主要原材料、流通業者、顧客の分析。
第13章：市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。
第14章：レポートの要点と結論。


ページTOPに戻る


目次

1 Study Coverage
1.1 Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
1.2.2 Purity＜95%
1.2.3 Purity ≥95%
1.3 Market by Application
1.3.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
1.3.2 University
1.3.3 Research Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue Estimates and Forecasts 2020-2031
2.2 Global Revenue by Region
2.2.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Region: 2020 VS 2024 VS 2031
2.2.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Region (2020-2031)
2.2.3 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue Market Share by Region (2020-2031)
2.3 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales Estimates and Forecasts 2020-2031
2.4 Global Sales by Region
2.4.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Region: 2020 VS 2024 VS 2031
2.4.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Region (2020-2031)
2.4.3 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales Market Share by Region (2020-2031)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Sales by Manufacturers
3.1.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Manufacturers (2020-2025)
3.1.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales Market Share by Manufacturers (2020-2025)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Human Bone Morphogenetic Protein 9 Reagent in 2024
3.2 Global Revenue by Manufacturers
3.2.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Manufacturers (2020-2025)
3.2.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue Market Share by Manufacturers (2020-2025)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue in 2024
3.3 Global Key Players of Recombinant Human Bone Morphogenetic Protein 9 Reagent, Industry Ranking, 2023 VS 2024
3.4 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales Price by Manufacturers (2020-2025)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Recombinant Human Bone Morphogenetic Protein 9 Reagent, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Recombinant Human Bone Morphogenetic Protein 9 Reagent, Product Offered and Application
3.8 Global Key Manufacturers of Recombinant Human Bone Morphogenetic Protein 9 Reagent, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Sales by Type
4.1.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Historical Sales by Type (2020-2025)
4.1.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Forecasted Sales by Type (2026-2031)
4.1.3 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales Market Share by Type (2020-2031)
4.2 Global Revenue by Type
4.2.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Historical Revenue by Type (2020-2025)
4.2.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Forecasted Revenue by Type (2026-2031)
4.2.3 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue Market Share by Type (2020-2031)
4.3 Global Price by Type
4.3.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Price by Type (2020-2025)
4.3.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Price Forecast by Type (2026-2031)
5 Market Size by Application
5.1 Global Sales by Application
5.1.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Historical Sales by Application (2020-2025)
5.1.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Forecasted Sales by Application (2026-2031)
5.1.3 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales Market Share by Application (2020-2031)
5.2 Global Revenue by Application
5.2.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Historical Revenue by Application (2020-2025)
5.2.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Forecasted Revenue by Application (2026-2031)
5.2.3 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue Market Share by Application (2020-2031)
5.3 Global Price by Application
5.3.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Price by Application (2020-2025)
5.3.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Price Forecast by Application (2026-2031)
6 US & Canada
6.1 US & Canada Market Size by Type
6.1.1 US & Canada Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Type (2020-2031)
6.1.2 US & Canada Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Type (2020-2031)
6.2 US & Canada Market Size by Application
6.2.1 US & Canada Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Application (2020-2031)
6.2.2 US & Canada Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Application (2020-2031)
6.3 US & Canada Market Size by Country
6.3.1 US & Canada Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Country: 2020 VS 2024 VS 2031
6.3.2 US & Canada Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Country (2020-2031)
6.3.3 US & Canada Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Country (2020-2031)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Market Size by Type
7.1.1 Europe Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Type (2020-2031)
7.1.2 Europe Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Type (2020-2031)
7.2 Europe Market Size by Application
7.2.1 Europe Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Application (2020-2031)
7.2.2 Europe Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Application (2020-2031)
7.3 Europe Market Size by Country
7.3.1 Europe Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Country: 2020 VS 2024 VS 2031
7.3.2 Europe Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Country (2020-2031)
7.3.3 Europe Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Country (2020-2031)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Market Size by Type
8.1.1 China Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Type (2020-2031)
8.1.2 China Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Type (2020-2031)
8.2 China Market Size by Application
8.2.1 China Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Application (2020-2031)
8.2.2 China Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Application (2020-2031)
9 Asia (excluding China)
9.1 Asia Market Size by Type
9.1.1 Asia Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Type (2020-2031)
9.1.2 Asia Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Type (2020-2031)
9.2 Asia Market Size by Application
9.2.1 Asia Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Application (2020-2031)
9.2.2 Asia Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Application (2020-2031)
9.3 Asia Market Size by Region
9.3.1 Asia Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Region: 2020 VS 2024 VS 2031
9.3.2 Asia Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Region (2020-2031)
9.3.3 Asia Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Region (2020-2031)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Market Size by Type
10.1.1 Middle East, Africa and Latin America Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Type (2020-2031)
10.1.2 Middle East, Africa and Latin America Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Type (2020-2031)
10.2 Middle East, Africa and Latin America Market Size by Application
10.2.1 Middle East, Africa and Latin America Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Application (2020-2031)
10.2.2 Middle East, Africa and Latin America Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Application (2020-2031)
10.3 Middle East, Africa and Latin America Market Size by Country
10.3.1 Middle East, Africa and Latin America Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Country: 2020 VS 2024 VS 2031
10.3.2 Middle East, Africa and Latin America Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Country (2020-2031)
10.3.3 Middle East, Africa and Latin America Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Country (2020-2031)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Information
11.1.2 Thermo Fisher Scientific Inc. Overview
11.1.3 Thermo Fisher Scientific Inc. Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.4 Thermo Fisher Scientific Inc. Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Thermo Fisher Scientific Inc. Recent Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Company Information
11.2.2 Bio-Techne Overview
11.2.3 Bio-Techne Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.4 Bio-Techne Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bio-Techne Recent Developments
11.3 Scientists Helping Scientists
11.3.1 Scientists Helping Scientists Company Information
11.3.2 Scientists Helping Scientists Overview
11.3.3 Scientists Helping Scientists Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.4 Scientists Helping Scientists Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Scientists Helping Scientists Recent Developments
11.4 Abcam Limited
11.4.1 Abcam Limited Company Information
11.4.2 Abcam Limited Overview
11.4.3 Abcam Limited Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.4 Abcam Limited Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Abcam Limited Recent Developments
11.5 FUJIFILM Irvine Scientific
11.5.1 FUJIFILM Irvine Scientific Company Information
11.5.2 FUJIFILM Irvine Scientific Overview
11.5.3 FUJIFILM Irvine Scientific Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.4 FUJIFILM Irvine Scientific Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 FUJIFILM Irvine Scientific Recent Developments
11.6 BD Biosciences
11.6.1 BD Biosciences Company Information
11.6.2 BD Biosciences Overview
11.6.3 BD Biosciences Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.4 BD Biosciences Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BD Biosciences Recent Developments
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Bio-Rad Laboratories, Inc. Company Information
11.7.2 Bio-Rad Laboratories, Inc. Overview
11.7.3 Bio-Rad Laboratories, Inc. Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.4 Bio-Rad Laboratories, Inc. Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bio-Rad Laboratories, Inc. Recent Developments
11.8 BPS Bioscience, Inc.
11.8.1 BPS Bioscience, Inc. Company Information
11.8.2 BPS Bioscience, Inc. Overview
11.8.3 BPS Bioscience, Inc. Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.4 BPS Bioscience, Inc. Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BPS Bioscience, Inc. Recent Developments
11.9 Elabscience
11.9.1 Elabscience Company Information
11.9.2 Elabscience Overview
11.9.3 Elabscience Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.4 Elabscience Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Elabscience Recent Developments
11.10 Yisheng Biotechnology (Shanghai) Co., Ltd.
11.10.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
11.10.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Overview
11.10.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Developments
11.11 Abbkine
11.11.1 Abbkine Company Information
11.11.2 Abbkine Overview
11.11.3 Abbkine Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.4 Abbkine Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Abbkine Recent Developments
11.12 Beijing Biocreative Technology Co., Ltd.
11.12.1 Beijing Biocreative Technology Co., Ltd. Company Information
11.12.2 Beijing Biocreative Technology Co., Ltd. Overview
11.12.3 Beijing Biocreative Technology Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.4 Beijing Biocreative Technology Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Beijing Biocreative Technology Co., Ltd. Recent Developments
11.13 Shanghai Yaji Biotechnology Co., Ltd.
11.13.1 Shanghai Yaji Biotechnology Co., Ltd. Company Information
11.13.2 Shanghai Yaji Biotechnology Co., Ltd. Overview
11.13.3 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.4 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Shanghai Yaji Biotechnology Co., Ltd. Recent Developments
11.14 Cellverse Co., Ltd.
11.14.1 Cellverse Co., Ltd. Company Information
11.14.2 Cellverse Co., Ltd. Overview
11.14.3 Cellverse Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.4 Cellverse Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Cellverse Co., Ltd. Recent Developments
11.15 Dalian Meilun Biotech Co., Ltd.
11.15.1 Dalian Meilun Biotech Co., Ltd. Company Information
11.15.2 Dalian Meilun Biotech Co., Ltd. Overview
11.15.3 Dalian Meilun Biotech Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.4 Dalian Meilun Biotech Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Dalian Meilun Biotech Co., Ltd. Recent Developments
11.16 Sino Biological,Inc.
11.16.1 Sino Biological,Inc. Company Information
11.16.2 Sino Biological,Inc. Overview
11.16.3 Sino Biological,Inc. Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.4 Sino Biological,Inc. Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Sino Biological,Inc. Recent Developments
11.17 Prospec-Tany Technogene Ltd
11.17.1 Prospec-Tany Technogene Ltd Company Information
11.17.2 Prospec-Tany Technogene Ltd Overview
11.17.3 Prospec-Tany Technogene Ltd Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.4 Prospec-Tany Technogene Ltd Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Prospec-Tany Technogene Ltd Recent Developments
11.18 ENZO
11.18.1 ENZO Company Information
11.18.2 ENZO Overview
11.18.3 ENZO Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.4 ENZO Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 ENZO Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Human Bone Morphogenetic Protein 9 Reagent Industry Chain Analysis
12.2 Recombinant Human Bone Morphogenetic Protein 9 Reagent Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Human Bone Morphogenetic Protein 9 Reagent Production Mode & Process
12.4 Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales and Marketing
12.4.1 Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales Channels
12.4.2 Recombinant Human Bone Morphogenetic Protein 9 Reagent Distributors
12.5 Recombinant Human Bone Morphogenetic Protein 9 Reagent Customers
13 Recombinant Human Bone Morphogenetic Protein 9 Reagent Market Dynamics
13.1 Recombinant Human Bone Morphogenetic Protein 9 Reagent Industry Trends
13.2 Recombinant Human Bone Morphogenetic Protein 9 Reagent Market Drivers
13.3 Recombinant Human Bone Morphogenetic Protein 9 Reagent Market Challenges
13.4 Recombinant Human Bone Morphogenetic Protein 9 Reagent Market Restraints
14 Key Findings in the Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

　

ページTOPに戻る


　

Summary

The global Recombinant Human Bone Morphogenetic Protein 9 Reagent market is projected to grow from US$ 107 million in 2025 to US$ 165 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.
Bone morphogenetic proteins (BMPs) are expressed in different cell types of human ovarian follicles and play an important role in the regulation of ovarian function. BMP-9, also known as growth differentiation factor-2 (GDF-2), belongs to the transforming growth factor-β (TGF-β) superfamily. BMP-9 is mainly synthesized in the liver and secreted into the blood, thereby regulating various physiological and pathological functions.

The US & Canada market for Recombinant Human Bone Morphogenetic Protein 9 Reagent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Recombinant Human Bone Morphogenetic Protein 9 Reagent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Recombinant Human Bone Morphogenetic Protein 9 Reagent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key manufacturers of Recombinant Human Bone Morphogenetic Protein 9 Reagent include Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, BD Biosciences, Bio-Rad Laboratories, Inc., BPS Bioscience, Inc., Elabscience, Yisheng Biotechnology (Shanghai) Co., Ltd., etc. In 2024, the global top five players had a share approximately % in terms of revenue.
In terms of consumption side, this report focuses on the sales of Recombinant Human Bone Morphogenetic Protein 9 Reagent by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.

This report presents an overview of global market for Recombinant Human Bone Morphogenetic Protein 9 Reagent, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Recombinant Human Bone Morphogenetic Protein 9 Reagent, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Recombinant Human Bone Morphogenetic Protein 9 Reagent, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant Human Bone Morphogenetic Protein 9 Reagent sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Recombinant Human Bone Morphogenetic Protein 9 Reagent market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Recombinant Human Bone Morphogenetic Protein 9 Reagent sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, BD Biosciences, Bio-Rad Laboratories, Inc., BPS Bioscience, Inc., Elabscience, Yisheng Biotechnology (Shanghai) Co., Ltd., etc.

Market Segmentation
By Company
Thermo Fisher Scientific Inc.
Bio-Techne
Scientists Helping Scientists
Abcam Limited
FUJIFILM Irvine Scientific
BD Biosciences
Bio-Rad Laboratories, Inc.
BPS Bioscience, Inc.
Elabscience
Yisheng Biotechnology (Shanghai) Co., Ltd.
Abbkine
Beijing Biocreative Technology Co., Ltd.
Shanghai Yaji Biotechnology Co., Ltd.
Cellverse Co., Ltd.
Dalian Meilun Biotech Co., Ltd.
Sino Biological,Inc.
Prospec-Tany Technogene Ltd
ENZO
Segment by Type
Purity＜95%
Purity ≥95%
Segment by Application
University
Research Center
Production by Region
North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Recombinant Human Bone Morphogenetic Protein 9 Reagent in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Recombinant Human Bone Morphogenetic Protein 9 Reagent manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Human Bone Morphogenetic Protein 9 Reagent sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
1.2.2 Purity＜95%
1.2.3 Purity ≥95%
1.3 Market by Application
1.3.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
1.3.2 University
1.3.3 Research Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue Estimates and Forecasts 2020-2031
2.2 Global Revenue by Region
2.2.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Region: 2020 VS 2024 VS 2031
2.2.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Region (2020-2031)
2.2.3 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue Market Share by Region (2020-2031)
2.3 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales Estimates and Forecasts 2020-2031
2.4 Global Sales by Region
2.4.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Region: 2020 VS 2024 VS 2031
2.4.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Region (2020-2031)
2.4.3 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales Market Share by Region (2020-2031)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Sales by Manufacturers
3.1.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Manufacturers (2020-2025)
3.1.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales Market Share by Manufacturers (2020-2025)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Human Bone Morphogenetic Protein 9 Reagent in 2024
3.2 Global Revenue by Manufacturers
3.2.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Manufacturers (2020-2025)
3.2.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue Market Share by Manufacturers (2020-2025)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue in 2024
3.3 Global Key Players of Recombinant Human Bone Morphogenetic Protein 9 Reagent, Industry Ranking, 2023 VS 2024
3.4 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales Price by Manufacturers (2020-2025)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Recombinant Human Bone Morphogenetic Protein 9 Reagent, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Recombinant Human Bone Morphogenetic Protein 9 Reagent, Product Offered and Application
3.8 Global Key Manufacturers of Recombinant Human Bone Morphogenetic Protein 9 Reagent, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Sales by Type
4.1.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Historical Sales by Type (2020-2025)
4.1.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Forecasted Sales by Type (2026-2031)
4.1.3 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales Market Share by Type (2020-2031)
4.2 Global Revenue by Type
4.2.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Historical Revenue by Type (2020-2025)
4.2.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Forecasted Revenue by Type (2026-2031)
4.2.3 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue Market Share by Type (2020-2031)
4.3 Global Price by Type
4.3.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Price by Type (2020-2025)
4.3.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Price Forecast by Type (2026-2031)
5 Market Size by Application
5.1 Global Sales by Application
5.1.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Historical Sales by Application (2020-2025)
5.1.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Forecasted Sales by Application (2026-2031)
5.1.3 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales Market Share by Application (2020-2031)
5.2 Global Revenue by Application
5.2.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Historical Revenue by Application (2020-2025)
5.2.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Forecasted Revenue by Application (2026-2031)
5.2.3 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue Market Share by Application (2020-2031)
5.3 Global Price by Application
5.3.1 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Price by Application (2020-2025)
5.3.2 Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Price Forecast by Application (2026-2031)
6 US & Canada
6.1 US & Canada Market Size by Type
6.1.1 US & Canada Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Type (2020-2031)
6.1.2 US & Canada Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Type (2020-2031)
6.2 US & Canada Market Size by Application
6.2.1 US & Canada Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Application (2020-2031)
6.2.2 US & Canada Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Application (2020-2031)
6.3 US & Canada Market Size by Country
6.3.1 US & Canada Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Country: 2020 VS 2024 VS 2031
6.3.2 US & Canada Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Country (2020-2031)
6.3.3 US & Canada Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Country (2020-2031)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Market Size by Type
7.1.1 Europe Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Type (2020-2031)
7.1.2 Europe Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Type (2020-2031)
7.2 Europe Market Size by Application
7.2.1 Europe Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Application (2020-2031)
7.2.2 Europe Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Application (2020-2031)
7.3 Europe Market Size by Country
7.3.1 Europe Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Country: 2020 VS 2024 VS 2031
7.3.2 Europe Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Country (2020-2031)
7.3.3 Europe Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Country (2020-2031)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Market Size by Type
8.1.1 China Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Type (2020-2031)
8.1.2 China Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Type (2020-2031)
8.2 China Market Size by Application
8.2.1 China Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Application (2020-2031)
8.2.2 China Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Application (2020-2031)
9 Asia (excluding China)
9.1 Asia Market Size by Type
9.1.1 Asia Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Type (2020-2031)
9.1.2 Asia Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Type (2020-2031)
9.2 Asia Market Size by Application
9.2.1 Asia Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Application (2020-2031)
9.2.2 Asia Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Application (2020-2031)
9.3 Asia Market Size by Region
9.3.1 Asia Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Region: 2020 VS 2024 VS 2031
9.3.2 Asia Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Region (2020-2031)
9.3.3 Asia Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Region (2020-2031)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Market Size by Type
10.1.1 Middle East, Africa and Latin America Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Type (2020-2031)
10.1.2 Middle East, Africa and Latin America Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Type (2020-2031)
10.2 Middle East, Africa and Latin America Market Size by Application
10.2.1 Middle East, Africa and Latin America Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Application (2020-2031)
10.2.2 Middle East, Africa and Latin America Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Application (2020-2031)
10.3 Middle East, Africa and Latin America Market Size by Country
10.3.1 Middle East, Africa and Latin America Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Country: 2020 VS 2024 VS 2031
10.3.2 Middle East, Africa and Latin America Recombinant Human Bone Morphogenetic Protein 9 Reagent Revenue by Country (2020-2031)
10.3.3 Middle East, Africa and Latin America Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales by Country (2020-2031)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Information
11.1.2 Thermo Fisher Scientific Inc. Overview
11.1.3 Thermo Fisher Scientific Inc. Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.4 Thermo Fisher Scientific Inc. Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Thermo Fisher Scientific Inc. Recent Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Company Information
11.2.2 Bio-Techne Overview
11.2.3 Bio-Techne Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.4 Bio-Techne Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bio-Techne Recent Developments
11.3 Scientists Helping Scientists
11.3.1 Scientists Helping Scientists Company Information
11.3.2 Scientists Helping Scientists Overview
11.3.3 Scientists Helping Scientists Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.4 Scientists Helping Scientists Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Scientists Helping Scientists Recent Developments
11.4 Abcam Limited
11.4.1 Abcam Limited Company Information
11.4.2 Abcam Limited Overview
11.4.3 Abcam Limited Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.4 Abcam Limited Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Abcam Limited Recent Developments
11.5 FUJIFILM Irvine Scientific
11.5.1 FUJIFILM Irvine Scientific Company Information
11.5.2 FUJIFILM Irvine Scientific Overview
11.5.3 FUJIFILM Irvine Scientific Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.4 FUJIFILM Irvine Scientific Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 FUJIFILM Irvine Scientific Recent Developments
11.6 BD Biosciences
11.6.1 BD Biosciences Company Information
11.6.2 BD Biosciences Overview
11.6.3 BD Biosciences Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.4 BD Biosciences Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BD Biosciences Recent Developments
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Bio-Rad Laboratories, Inc. Company Information
11.7.2 Bio-Rad Laboratories, Inc. Overview
11.7.3 Bio-Rad Laboratories, Inc. Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.4 Bio-Rad Laboratories, Inc. Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bio-Rad Laboratories, Inc. Recent Developments
11.8 BPS Bioscience, Inc.
11.8.1 BPS Bioscience, Inc. Company Information
11.8.2 BPS Bioscience, Inc. Overview
11.8.3 BPS Bioscience, Inc. Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.4 BPS Bioscience, Inc. Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BPS Bioscience, Inc. Recent Developments
11.9 Elabscience
11.9.1 Elabscience Company Information
11.9.2 Elabscience Overview
11.9.3 Elabscience Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.4 Elabscience Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Elabscience Recent Developments
11.10 Yisheng Biotechnology (Shanghai) Co., Ltd.
11.10.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
11.10.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Overview
11.10.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Developments
11.11 Abbkine
11.11.1 Abbkine Company Information
11.11.2 Abbkine Overview
11.11.3 Abbkine Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.4 Abbkine Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Abbkine Recent Developments
11.12 Beijing Biocreative Technology Co., Ltd.
11.12.1 Beijing Biocreative Technology Co., Ltd. Company Information
11.12.2 Beijing Biocreative Technology Co., Ltd. Overview
11.12.3 Beijing Biocreative Technology Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.4 Beijing Biocreative Technology Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Beijing Biocreative Technology Co., Ltd. Recent Developments
11.13 Shanghai Yaji Biotechnology Co., Ltd.
11.13.1 Shanghai Yaji Biotechnology Co., Ltd. Company Information
11.13.2 Shanghai Yaji Biotechnology Co., Ltd. Overview
11.13.3 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.4 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Shanghai Yaji Biotechnology Co., Ltd. Recent Developments
11.14 Cellverse Co., Ltd.
11.14.1 Cellverse Co., Ltd. Company Information
11.14.2 Cellverse Co., Ltd. Overview
11.14.3 Cellverse Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.4 Cellverse Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Cellverse Co., Ltd. Recent Developments
11.15 Dalian Meilun Biotech Co., Ltd.
11.15.1 Dalian Meilun Biotech Co., Ltd. Company Information
11.15.2 Dalian Meilun Biotech Co., Ltd. Overview
11.15.3 Dalian Meilun Biotech Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.4 Dalian Meilun Biotech Co., Ltd. Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Dalian Meilun Biotech Co., Ltd. Recent Developments
11.16 Sino Biological,Inc.
11.16.1 Sino Biological,Inc. Company Information
11.16.2 Sino Biological,Inc. Overview
11.16.3 Sino Biological,Inc. Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.4 Sino Biological,Inc. Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Sino Biological,Inc. Recent Developments
11.17 Prospec-Tany Technogene Ltd
11.17.1 Prospec-Tany Technogene Ltd Company Information
11.17.2 Prospec-Tany Technogene Ltd Overview
11.17.3 Prospec-Tany Technogene Ltd Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.4 Prospec-Tany Technogene Ltd Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Prospec-Tany Technogene Ltd Recent Developments
11.18 ENZO
11.18.1 ENZO Company Information
11.18.2 ENZO Overview
11.18.3 ENZO Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.4 ENZO Recombinant Human Bone Morphogenetic Protein 9 Reagent Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 ENZO Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Human Bone Morphogenetic Protein 9 Reagent Industry Chain Analysis
12.2 Recombinant Human Bone Morphogenetic Protein 9 Reagent Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Human Bone Morphogenetic Protein 9 Reagent Production Mode & Process
12.4 Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales and Marketing
12.4.1 Recombinant Human Bone Morphogenetic Protein 9 Reagent Sales Channels
12.4.2 Recombinant Human Bone Morphogenetic Protein 9 Reagent Distributors
12.5 Recombinant Human Bone Morphogenetic Protein 9 Reagent Customers
13 Recombinant Human Bone Morphogenetic Protein 9 Reagent Market Dynamics
13.1 Recombinant Human Bone Morphogenetic Protein 9 Reagent Industry Trends
13.2 Recombinant Human Bone Morphogenetic Protein 9 Reagent Market Drivers
13.3 Recombinant Human Bone Morphogenetic Protein 9 Reagent Market Challenges
13.4 Recombinant Human Bone Morphogenetic Protein 9 Reagent Market Restraints
14 Key Findings in the Global Recombinant Human Bone Morphogenetic Protein 9 Reagent Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

QYResearch社の医療機器・消耗品分野での最新刊レポート

本レポートと同じKEY WORD（protein）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2025/04/18　10:27

143.46 円

163.28 円

193.29 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.